{"version":"1.0","type":"link","title":"Thyroid-stimulating immunoglobulin is not associated with aggressive clinicopathologic features in concomitant Graves' disease and papillary thyroid cancer.","author_name":"Finnerty BM 외","author_url":"https://prs-insight.online/author/Finnerty%20BM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/140491","thumbnail_width":1200,"thumbnail_height":630}